Pulmonary toxicity from novel antineoplastic agents

Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.

Agents commonly used in the treatment of neoplastic diseases may impair pulmonary function, and a wide spectrum of agents are currently implicated as toxic to the pulmonary system. Agents most commonly implicated are bleomycin, carmustine, busulfan, methotrexate, and thoracic radiotherapy. Less commonly implicated agents include mitomycin, procarbazine, melphalan, chlorambucil, and cyclophospha...

Antineoplastic Agents for Solid Tumors Pulmonary Complications of Novel

2008;133;528-538 Chest Bobbak Vahid and Paul E. Marik Antineoplastic Agents for Solid Tumors Pulmonary Complications of Novel http://chestjournal.org/cgi/content/abstract/133/2/528 and services can be found online on the World Wide Web at: The online version of this article, along with updated information ). ISSN: 0012-3692. http://www.chestjournal.org/misc/reprints.shtml ( of the copyright hol...

Antineoplastic Agents

Re: Thyroid dysfunction from antineoplastic agents.

In a recent review of thyroid dysfunction induced by antineoplastic agents, Hamnvik et al. (1) highlighted hypothyroidism as a common side effect of certain anticancer agents, an effect with the potential for favorably modifying outcomes in cancer patients. The article indicates that spontaneous or intentionally induced hypothyroidism may be associated with better clinical response rates and lo...

Pulmonary toxicity induced by chemical agents.

place special stress on the lung. pleural space can lead to severe transplantation is associated with the of right-sided pleural effusions and right atelectasis, presumably due to subdissection. Most transplantation patients volumes of intravenous fluids and have some underlying disease which can directly or indirectly. The ability of BAL lung is helpful in assessment of the of pulmonary compli...